StockData
Rapid Micro Biosystems, Inc. logo

Rapid Micro Biosystems, Inc. (RPID) stock

RPIDNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 7/3050% below fair value
$0.74−0.00 (-0.43%)

Close on Nov 17, 2026Market cap $36.96MP/E –Yield –

Rapid Micro Biosystems revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Rapid Micro Biosystems's revenue for the twelve months ending Jun 30, 2026 was $35.18M, up 16.1% year over year. For fiscal 2025 it was $33.59M, up 19.7% from the year before. The highest annual figure on record is $33.59M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$33.59M+19.7%
FY2024Dec 31, 2024$28.05M+24.6%
FY2023Dec 31, 2023$22.52M+31.4%
FY2022Dec 31, 2022$17.13M-26.3%
FY2021Dec 31, 2021$23.23M+44.5%
FY2020Dec 31, 2020$16.08M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$8.05M+10.9%
Q1 FY2026Mar 31, 2026$8.00M+11.1%
Q4 FY2025Dec 31, 2025$11.28M+37.3%
Q3 FY2025Sep 30, 2025$7.84M+3.1%
Q2 FY2025Jun 30, 2025$7.26M+9.7%
Q1 FY2025Mar 31, 2025$7.21M+28.4%
Q4 FY2024Dec 31, 2024$8.22M+29.7%
Q3 FY2024Sep 30, 2024$7.60M+23.7%
Q2 FY2024Jun 30, 2024$6.62M+32.3%
Q1 FY2024Mar 31, 2024$5.61M+11.4%
Q4 FY2023Dec 31, 2023$6.34M+44.9%
Q3 FY2023Sep 30, 2023$6.15M+29.7%
Q2 FY2023Jun 30, 2023$5.00M+29.6%
Q1 FY2023Mar 31, 2023$5.04M+21.0%
Q4 FY2022Dec 31, 2022$4.37M-16.0%
Q3 FY2022Sep 30, 2022$4.74M-31.3%
Q2 FY2022Jun 30, 2022$3.86M-37.0%
Q1 FY2022Mar 31, 2022$4.16M-16.7%
Q4 FY2021Dec 31, 2021$5.21M-0.6%
Q3 FY2021Sep 30, 2021$6.90M+31.5%
Q2 FY2021Jun 30, 2021$6.13M+136.4%
Q1 FY2021Mar 31, 2021$5.00M–
Q4 FY2020Dec 31, 2020$5.24M–
Q3 FY2020Sep 30, 2020$5.25M–
Q2 FY2020Jun 30, 2020$2.59M–

More Rapid Micro Biosystems figures

See a number that looks wrong?